［1］Jia XB.Research progress in diagnosis and prevention of venous thromboembolic disease after gynecologic cancer surgery［J］.Journal of Practical Obstetrics and Gynecology，2015，31(1)：23-25.［贾西彪.妇科肿瘤术后静脉血栓栓塞性疾病诊治及预防的研究进展［J］.实用妇产科杂志，2015，31(1)：23-25.］
［2］Yang SR，Zhang RL，Guo LN，et al.Detection and significance of tissue factor and tissue factor pathway inhibitor of gynecological malignant tumor patients with postoperative deep vein thrombosis［J］.Acta Academiae Medicinae Weifang，2015，9(4)：298-299.［杨素荣，张瑞莲，郭莉娜，等.妇科恶性肿瘤术后深静脉血栓形成患者组织因子及其途径抑制物的检测及意义［J］.潍坊医学院学报，2015，9(4)：298-299.］
［3］Fei X，Wang H，Yuan W，et al.Tissue factor pathway inhibitor-1 is a valuable marker for the prediction of deep venous thrombosis and tumor metastasis in patients with lung cancer［J］.Biomed Res Int，2017，2017(6)：8983763.
［4］Claussen C，Rausch AV，Lezius S，et al.Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer［J］.Thromb Res，2016，141：39-48.
［5］Cui CJ，Wang GJ，Yang S，et al.Tissue factor-bearing MPs and the risk of venous thrombosis in cancer patients：A Meta-analysis［J］.Sci Rep，2018，8(1)：1675.
［6］Sakurai M，Matsumoto K，Gosho M，et al.Expression of tissue factor in epithelial ovarian carcinoma is involved in the development of venous thromboembolism［J］.Int J Gynecol Cancer，2017，27(1)：37-43.
［7］Gajsiewicz JM，Morrissey JH.Structure-function relationship of the interaction between tissue factor and factor Ⅶa［J］.Semin Thromb Hemost，2015，41(7)：682-690.
［8］Ma J，Li X，Wang Y，et al.Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus［J］.Int J Molecular Med，2017，40(6)：1869.
［9］Eriksson O，sa Thulin，Asplund A，et al.Cross-talk between the tissue factor/coagulation factor viia complex and the tyrosine kinase receptor EphA2 in cancer［J］.BMC Cancer，2016，16(1)：1-14.
［10］Cohen JG，Prendergast E，Geddings JE，et al.Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer［J］.Gynecol Oncol，2017，146(1)：146.
［11］Bang E，Tanabe K，Yokoyama N，et al.Relationship between thigh intermuscular adipose tissue accumulation and number of metabolicsyndrome risk factors in middle-aged and older Japanese adults［J］.Exp Gerontol，2016，15，79：26-30.
［12］Liu Y，Zhou J，Liu Y，et al.Research progress in the mechanism of coagulation disorders in breast cancer［J］.Journal of Medical Research，2014，43(8)：10-13，117.［刘玥，周晋，刘岩，等.乳腺癌凝血紊乱机制研究进展［J］.医学研究杂志，2014，43(8)：10-13，117.］
［13］Miao W，Zhao K，Deng W，et al.Coagulation factor hyperfunction after subarachnoid hemorrhage induces deep venous thrombosis［J］.World Neurosurg，2018，110(2)：33-39.
［14］Woeiajin FJSH，Tesselaar MET，Rodriguez PG，et al.Tissue factor-bearing microparticles and CA19-9：Two players in pancreatic cancer-associated thrombosis［J］？Br J Cancer，2016，115(3)：332-338.
［15］Deng C，Cao X，Lin QC，et al.Effects of tissue factor and tissue factor pathway inhibitor-1 on lung adenocarcinoma with venous thromboembolism［J］.Chest，2016，149(4)：A287-A287.
［16］Li HL，Zhang DJ，Zhang DJ，et al.Changes of blood coagulation and fibrinolysis functions and plasma thrombomodulin levels in patients with hemorrhagic fever with renal syndrome［J］.Chinese Journal of Infectious Diseases，2013，31(12)：733-739.
［17］Konoeda H，Yamaki T，Hamahata A，et al.Incidence of deep vein thrombosis in patients undergoing breast reconstruction with autologous tissue transfer［J］.Phlebology，2016，32(4)：282.
［18］Cote DJ，Smith TR.Venous thromboembolism in brain tumor patients［J］.J Clin Neurosci，2016，25(4)：13-18.
［19］Ellery PE，Maroney SA，Cooley BC，et al.A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development［J］.Blood，2015，125(26)：4078-4084.